ask="N/A"
ask_size="N/A"
average_daily_volume="35994"
bid="2.6100"
bid_size="300"
book_value="0.4940"
change="-0.0101"
change_from_200_day_moving_average="-0.8808"
change_from_50_day_moving_average="-0.5737"
change_from_52_week_high="-6.2201"
change_From_52_week_low="0.3099"
change_in_percent="-0.3620%"
close="2.7799"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.4210"
ebitda="-15.65M"
eps_estimate_current_year="-1.6200"
eps_estimate_next_quarter="-0.3600"
eps_estimate_next_year="-1.4900"
ex_dividend_date="N/A"
float_shares="4342000"
high="2.8400"
high_52_weeks="9.0000"
last_trade_date="2/9/2017"
last_trade_price="2.7799"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.6850"
low_52_weeks="2.4700"
market_capitalization="23.29M"
moving_average_200_day="3.6607"
moving_average_50_day="3.3536"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.5000"
open="2.7500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-24.0614%"
percent_change_from_50_day_moving_average="-17.1080%"
percent_change_from_52_week_high="-69.1122%"
percent_change_from_52_week_low="+12.5466%"
previous_close="2.7900"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.6478"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.2900"
stock_exchange="NCM"
symbol="VTGN"
volume="36599"
weeks_range_52="2.4700 - 9.0000"
